Skip navigation
Know something we don't? Submit a conference announcement
Choose Category:

Sexually Transmitted Diseases meetings & conferences

4 meetings & conferences listed in Sexually Transmitted Diseases 

HPV 2015-- 30th International Papillomavirus Conference & Clinical and Public Health Workshops
Portugal
09/17/2015

HPV 2015-- 30th International Papillomavirus Conference & Clinical and Public Health Workshops

September 17-21, 2015 Lisbon, Portugal

Join us for the 30th International Papillomavirus Conference & Clinical and Public Health Workshops (HPV 2015) that will be held September 17-21 in Lisbon, Portugal. This year we will focus on HPV and Globalization, exploring new worlds in research as well as new proposals to reduce inequities in global health.

HPV gathers researchers, clinicians and other health professionals to share and exchange research regarding the epidemiology of HPV, virus vaccines, cervical cancer prevention and other papillomavirus associated diseases. We host an international forum that enables the exchange of knowledge between the research and clinical communities showcasing the latest advances in science and practice through state of the art oral and poster presentations.

Epidemiologist, Gynecologist, Physician Researcher, Public Health Expert, Public Health Worker, Public Servant, Virologist
Mechanisms of HIV Persistence: Implications for a Cure
United States
Massachusetts
04/26/2015

Mechanisms of HIV Persistence: Implications for a Cure

April 26—May 1, 2015 Boston, Massachusetts

Despite long-term control of HIV replication with cART, HIV persists as silenced integrated DNA in memory CD4 T cells, and possibly in other cellular reservoirs, including naïve cells and macrophages. Low level replenishment of the reservoir via limited cycles of replication, may also contribute to persistence, at least in some patients. Curing HIV infection will only occur if these barriers are reversed, or if host capacity to control HIV indefinitely is improved. A number of promising interventions which might reverse latent infection have been identified, and proof that such drugs affect HIV transcription in vivo provided in pilot clinical trials. The observation that few patients treated during primary infection control durably replication-competent HIV after interrupting therapy suggests host responses might be manipulated, leading to a functional cure. The path forward will require a detailed understanding of the mechanisms of viral latency which could lead to the identification of new drugs, and a better knowledge of the plasticity and dynamics of the main HIV cell reservoirs: CD4 T cells and macrophages. The role of the tissue microenvironment has to be underlined with the major help of non-human primate models. At the 2015 Keystone Symposia meeting on Mechanisms of HIV Persistence: Implications for a Cure, experts from both within and outside the HIV field will present findings from recent advances on immune mechanisms and therapeutic strategies which could lead to HIV cure.

Immunologist, Physician Researcher, Virologist
HIV Drug Therapy in the Americas 2015
Mexico
04/16/2015

HIV Drug Therapy in the Americas 2015

16-18 April 2015 Mexico City, Mexico

Pharmacologist, Physician Researcher, Public Health Expert
EUROGIN 2015 Congress
Spain
02/04/2015

EUROGIN 2015 Congress

Feb 4-7, 2015 Seville, Spain

The EUROGIN 2015 Congress aims at developing a full review of current scientific developments in the field of cervical cancer and human papillomavirus related diseases, raising the public health profile and increasing the need for responsible health services in this area.

The event endeavors to translate scientific and evidence-based research into clinical practice while highlighting the following aspects:

- Recent advances and updated scientific insights in HPV screening, testing and management

- The impact of HPV and associated cancers on public health

- Strategies to prevent and treat HPV related diseases

- Exchanging information on early detection, new diagnostic and therapeutic procedures and prevention strategies including screening and HPV vaccination

Speakers include international leaders from academic, government and private organizations, representatives of medical and scientific societies, as well as women's health associations who will discuss and exchange ideas on issues relevant to both individuals and public health

Gynecologist, Oncologist, Physician, Physician Researcher, Public Health Expert, Public Health Worker, Public Servant